These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14503802)

  • 1. Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.
    Colston KW; Pirianov G; Bramm E; Hamberg KJ; Binderup L
    Breast Cancer Res Treat; 2003 Aug; 80(3):303-11. PubMed ID: 14503802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
    Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
    Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY; Mercer E; Brady M; Binderup L; Colston KW
    Br J Pharmacol; 1998 Nov; 125(5):953-62. PubMed ID: 9846632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways.
    Macejová D; Ondková S; Jakubíková L; Mlynarčíková A; Scsuková S; Liška J; Brtko J
    Toxicol Lett; 2011 Nov; 207(1):60-72. PubMed ID: 21843606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z; Akhter J; Pourgholami MH; Morris DL
    Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.
    El Abdaimi K; Papavasiliou V; Rabbani SA; Rhim JS; Goltzman D; Kremer R
    Cancer Res; 1999 Jul; 59(14):3325-8. PubMed ID: 10416587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J; Papavasiliou V; Rhim J; Goltzman D; Kremer R
    Anticancer Drugs; 1995 Feb; 6(1):101-8. PubMed ID: 7756673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tissue-specific distribution of 3H-seocalcitol (EB 1089) and 3H-calcitriol in rats.
    Kissmeyer AM; Nielsen JL; Binderup L
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):43-7. PubMed ID: 15225745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089).
    Narayanan R; Allen MR; Gaddy D; Bloomfield SA; Smith CL; Weigel NL
    Bone; 2004 Jul; 35(1):134-43. PubMed ID: 15207749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
    Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
    Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
    Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
    J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.